Royal Bank of Canada Increases Stake in Mettler-Toledo International Inc. (NYSE:MTD)

Royal Bank of Canada grew its position in shares of Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 7.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 45,756 shares of the medical instruments supplier's stock after buying an additional 3,105 shares during the quarter. Royal Bank of Canada owned 0.22% of Mettler-Toledo International worth $55,990,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. JPMorgan Chase & Co. raised its position in Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after buying an additional 28,478 shares during the last quarter. Allworth Financial LP increased its holdings in shares of Mettler-Toledo International by 367.4% in the 4th quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock valued at $285,000 after purchasing an additional 169 shares in the last quarter. Robeco Institutional Asset Management B.V. increased its holdings in shares of Mettler-Toledo International by 18.0% in the 4th quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock valued at $42,058,000 after purchasing an additional 5,234 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. increased its holdings in shares of Mettler-Toledo International by 773.3% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 5,336 shares of the medical instruments supplier's stock valued at $6,530,000 after purchasing an additional 4,725 shares in the last quarter. Finally, Impax Asset Management Group plc increased its holdings in shares of Mettler-Toledo International by 5.8% in the 4th quarter. Impax Asset Management Group plc now owns 198,852 shares of the medical instruments supplier's stock valued at $243,331,000 after purchasing an additional 10,830 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the firm's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now directly owns 734 shares of the company's stock, valued at $964,248.46. This trade represents a 51.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.77% of the stock is owned by corporate insiders.

Analyst Ratings Changes

MTD has been the subject of a number of research analyst reports. Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a report on Monday, February 10th. StockNews.com downgraded shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a report on Monday, May 5th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and cut their price target for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. UBS Group upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their price target for the company from $1,530.00 to $1,350.00 in a report on Tuesday. Finally, Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target for the company in a report on Monday, April 7th. Seven analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $1,302.11.

Mettler-Toledo International Trading Up 2.3%

Shares of NYSE MTD opened at $1,185.46 on Wednesday. The stock has a market cap of $24.64 billion, a price-to-earnings ratio of 29.25, a PEG ratio of 3.30 and a beta of 1.40. Mettler-Toledo International Inc. has a 52 week low of $946.69 and a 52 week high of $1,546.93. The company's 50-day moving average price is $1,105.55 and its 200 day moving average price is $1,216.11.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating analysts' consensus estimates of $7.90 by $0.29. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The firm had revenue of $883.74 million for the quarter, compared to analysts' expectations of $876.61 million. During the same period in the prior year, the company earned $8.89 EPS. The firm's revenue was down 4.6% on a year-over-year basis. As a group, research analysts expect that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.